Skip to main content
AC

African Card Company A2C

Security and trust center evidence

a2ctunisie.comLast verified 2 Nov 2026

Summary

African Card Company A2C has 1 registry-verified row in the CertReports index, last verified 2 Nov 2026. The strongest row is PCI DSS: Listed on the Visa Global Registry as PCI DSS validated through 2027-02-28. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

African Card Company A2C is listed in the Visa Global Registry as PCI DSS validated through 28 Feb 2027, as of 26 Oct 2026. The registry entry shows the validation was issued on 30 Jun 2024 and the assessment was performed by SISA. As of 26 Oct 2026, no public evidence found for a SOC 2 report for African Card Company A2C. As of 26 Oct 2026, no public evidence found for a HIPAA BAA statement from African Card Company A2C. As of 26 Oct 2026, the PCI DSS registry listing is the only compliance evidence identified for this vendor.

  • PCI DSS - listed in Visa Global Registry, validated through 28 Feb 2027, issued 30 Jun 2024 (as of 26 Oct 2026).
  • SOC 2 - no public evidence found (as of 26 Oct 2026).
  • HIPAA - no public evidence found (as of 26 Oct 2026).

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 27 Oct 2026; it is regenerated whenever a row changes.

Evidence count

1verified rows

Compliance grid

No public evidence yet for HIPAA, SOC 2, GDPR, FedRAMP, ISO 27001, CSA STAR, Cyber Essentials, ISO 27701, ISO 42001. This does not mean the vendor lacks them; it means nothing public was found at the last check.

Subprocessors

No subprocessor list captured yet.

Change history

  1. 26 Oct 2026PCI DSS state changedState moved from Expired to Verified.
  2. 26 Oct 2026PCI DSS auditor changedAuditor changed from Foregenix Ltd. to SISA.
  3. 29 Sep 2026First indexed by CertReports1 evidence row across 1 framework entered the index.

How much of each regulation’s vendor requirements African Card Company A2C’s public evidence reaches.

All articles